Analysis of the Costs Associated with the Management of Adverse Events Compared Through Tkis in the Treatment of Patients with Non-Small Cells Lung Cancer EGFR Mutated

Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.2159
https://www.valueinhealthjournal.com/article/S1098-3015(16)33525-2/fulltext
Section Title : Disease-Specific Studies
Section Order : 2045
First Page : A723
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33525-2&doi=10.1016/j.jval.2016.09.2159
HEOR Topics :
Tags :
Regions :